PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsMultidrug-resistant tuberculosis
MeSH D018088 - multidrug-resistant tuberculosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D014376:Tuberculosis
$
Success rate
D018088: 
Multidrug-resistant tuberculosis
$
Success rate
D054908:Extensively drug-resistant tuberculosis
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
MylanPretomanid Dovprela (previously Pretomanid FGK)  2020-07-31   
Johnson & JohnsonBedaquiline Sirturo 2026-12-01 2012-12-28   
OtsukaDelamanid Deltyba  2014-04-27   
Clinical Trials
Historical Success Rate
Phase 1
100%
4/4
Phase 2
67%
16/24
Phase 3
57%
13/23
Approved: 4Overall Success rate: 38%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Johnson & Johnson
Otsuka
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use